Veterinary Medicines

Amoxitab 250 mg tablets for dogs

Authorised
  • Amoxicillin trihydrate
Download as PDF

Product identification

Medicine name:
Amoxitab 250 mg tablets for dogs
Amoxitab 250 mg Tabletten für Hunde
Active substance:
  • Amoxicillin trihydrate
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Amoxicillin trihydrate
    287.50
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CA04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Available in:
  • Germany
Package description:
  • (ID9) 90 Tablet: unspecified outer container with 9 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
  • (ID8) 80 Tablet: unspecified outer container with 8 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
  • (ID7) 70 Tablet: unspecified outer container with 7 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
  • (ID6) 60 Tablet: unspecified outer container with 6 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
  • (ID5) 50 Tablet: unspecified outer container with 5 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
  • (ID4) 40 Tablet: unspecified outer container with 4 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
  • (ID3) 30 Tablet: unspecified outer container with 3 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
  • (ID2) 20 Tablet: unspecified outer container with 2 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
  • (ID13) 100 Tablet: unspecified outer container with 10 unspecified outer container each with 1 Blister (Aluminium) with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
  • (ID12) 500 Tablet: unspecified outer container with 50 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
  • (ID11) 250 Tablet: unspecified outer container with 25 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
  • (ID10) 100 Tablet: unspecified outer container with 10 Blister (Aluminium) each with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)
  • (ID1) 10 Tablet: unspecified outer container with 1 Blister (Aluminium) with 10 Tablet, closed with Foil (PolyVinyl Chloride, PolyEthylene, PolyVinylidene Chloride)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • CP-Pharma Handelsgesellschaft mbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lelypharma B.V.
  • CP-Pharma Handelsgesellschaft mbH
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 402366.00.00
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0177/002
Concerned member states:
  • Sweden

Documents

Combined File of all Documents

English (PDF)
Published on: 18/12/2024
Download
German (PDF)
Published on: 18/12/2024
Download

2402366-paren-20161011.rtf

English (RTF)
Published on: 18/12/2024
Download